Track trials, findings, and clinical evidence as it lands.
Search papers, labs, and topics across Lattice.
1
0
0
0
It is argued that improvements in editing efficiency alone will be insufficient; clinical success will require the simultaneous achievement of tumor‐selective delivery, genomic integrity, and acceptable long‐term safety, and the continued development of novel approaches should be promoted to realize the full potential of CRISPR‐Cas9 technology in oncology and other therapeutic applications.